Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.
Clinical trial NCT03140176 · TERMINATED
Trial details
- NCT number
- NCT03140176
- Sponsor
- Pfizer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2017-08-15
- Primary completion
- 2022-01-22
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.